Risk factors for death in 1859 subjects with COVID-19
We studied 1859 subjects with confirmed COVID-19 from seven centers in Wuhan 1651 of whom recovered and 208 died. We interrogated diverse covariates for correlations with risk of death from COVID-19. In multi-variable Cox regression analyses increased hazards of in-hospital death were associated wit...
Uložené v:
| Vydané v: | Leukemia Ročník 34; číslo 8; s. 2173 - 2183 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
Nature Publishing Group UK
01.08.2020
Nature Publishing Group |
| Predmet: | |
| ISSN: | 0887-6924, 1476-5551, 1476-5551 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | We studied 1859 subjects with confirmed COVID-19 from seven centers in Wuhan 1651 of whom recovered and 208 died. We interrogated diverse covariates for correlations with risk of death from COVID-19. In multi-variable Cox regression analyses increased hazards of in-hospital death were associated with several admission covariates: (1) older age (HR = 1.04; 95% Confidence Interval [CI], 1.03, 1.06
per
year increase;
P
< 0.001); (2) smoking (HR = 1.84 [1.17, 2.92];
P
= 0.009); (3) admission temperature
per
°C increase (HR = 1.32 [1.07, 1.64];
P
= 0.009); (4) Log
10
neutrophil-to-lymphocyte ratio (NLR; HR = 3.30 [2.10, 5.19];
P
< 0.001); (5) platelets
per
10 E + 9/L decrease (HR = 0.996 [0.994, 0.998];
P
= 0.001); (6) activated partial thromboplastin (aPTT)
per
second increase (HR = 1.04 [1.02, 1.05];
P
< 0.001); (7) Log
10
D-dimer
per
mg/l increase (HR = 3.00 [2.17, 4.16];
P
< 0.001); and (8) Log
10
serum creatinine
per
μmol/L increase (HR = 4.55 [2.72, 7.62];
P
< 0.001). In piecewise linear regression analyses Log
10
NLR the interval from ≥0.4 to ≤1.0 was significantly associated with an increased risk of death. Our data identify covariates associated with risk of in hospital death in persons with COVID-19. |
|---|---|
| Bibliografia: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 0887-6924 1476-5551 1476-5551 |
| DOI: | 10.1038/s41375-020-0911-0 |